BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21590403)

  • 1. Herpes simplex virus type 1-derived recombinant and amplicon vectors.
    Fraefel C; Marconi P; Epstein AL
    Methods Mol Biol; 2011; 737():303-43. PubMed ID: 21590403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus type 1 (HSV-1)-derived recombinant vectors for gene transfer and gene therapy.
    Marconi P; Fraefel C; Epstein AL
    Methods Mol Biol; 2015; 1254():269-93. PubMed ID: 25431072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome.
    Saeki Y; Fraefel C; Ichikawa T; Breakefield XO; Chiocca EA
    Mol Ther; 2001 Apr; 3(4):591-601. PubMed ID: 11319922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of HSV-1 BACs and their use for packaging of HSV-1-based amplicon vectors.
    Heister TG; Vögtlin A; Müller L; Heid I; Fraefel C
    Methods Mol Biol; 2004; 256():241-56. PubMed ID: 15024170
    [No Abstract]   [Full Text] [Related]  

  • 5. Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors.
    Saeki Y; Ichikawa T; Saeki A; Chiocca EA; Tobler K; Ackermann M; Breakefield XO; Fraefel C
    Hum Gene Ther; 1998 Dec; 9(18):2787-94. PubMed ID: 9874276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic engineering of herpes simplex virus and vector genomes carrying loxP sites in cells expressing Cre recombinase.
    Logvinoff C; Epstein AL
    Virology; 2000 Feb; 267(1):102-10. PubMed ID: 10648187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene delivery using helper virus-free HSV-1 amplicon vectors.
    Laimbacher AS; Fraefel C
    Curr Protoc Neurosci; 2012 Jul; Chapter 4():Unit 4.14. PubMed ID: 22752894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene delivery using helper virus-free HSV-1 amplicon vectors.
    Fraefel C
    Curr Protoc Neurosci; 2007 Jul; Chapter 4():Unit 4.14. PubMed ID: 18428655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel approach for herpes simplex virus type 1 amplicon vector production, using the Cre-loxP recombination system to remove helper virus.
    Logvinoff C; Epstein AL
    Hum Gene Ther; 2001 Jan; 12(2):161-7. PubMed ID: 11177553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved packaging system for generation of high-level noncytotoxic HSV-1 amplicon vectors using Cre-loxP site-specific recombination to delete the packaging signals of defective helper genomes.
    Zaupa C; Revol-Guyot V; Epstein AL
    Hum Gene Ther; 2003 Jul; 14(11):1049-63. PubMed ID: 12885345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas.
    Pechan PA; Herrlinger U; Aghi M; Jacobs A; Breakefield XO
    J Gene Med; 1999; 1(3):176-85. PubMed ID: 10738566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased transcomplementation properties of plasmids carrying HSV-1 origin of replication and packaging signals.
    Berthomme H; Fournel S; Epstein AL
    Virology; 1996 Feb; 216(2):437-43. PubMed ID: 8607275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene delivery using helper virus-free HSV-1 amplicon vectors.
    Fraefel C
    Curr Protoc Hum Genet; 2002 Aug; Chapter 12():Unit 12.12. PubMed ID: 18428323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress and prospects: biological properties and technological advances of herpes simplex virus type 1-based amplicon vectors.
    Epstein AL
    Gene Ther; 2009 Jun; 16(6):709-15. PubMed ID: 19369969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus type 1 (HSV-1)-derived amplicon vectors.
    Melendez ME; Fraefel C; Epstein AL
    Methods Mol Biol; 2014; 1144():81-98. PubMed ID: 24671678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel 'piggyback' packaging system for herpes simplex virus amplicon vectors.
    Pechan PA; Fotaki M; Thompson RL; Dunn R; Chase M; Chiocca EA; Breakefield XO
    Hum Gene Ther; 1996 Oct; 7(16):2003-13. PubMed ID: 8930661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus type 1 (HSV-1)-derived amplicon vectors for gene transfer and gene therapy.
    Fraefel C; Marconi P; Epstein AL
    Methods Mol Biol; 2015; 1254():295-316. PubMed ID: 25431073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning of the herpes simplex virus type 1 genome as a novel luciferase-tagged infectious bacterial artificial chromosome.
    Li Y; Wang S; Zhu H; Zheng C
    Arch Virol; 2011 Dec; 156(12):2267-72. PubMed ID: 21894520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of a lambda phage recombination system and EGFP detection to simplify mutagenesis of Herpes simplex virus bacterial artificial chromosomes.
    Schmeisser F; Weir JP
    BMC Biotechnol; 2007 May; 7():22. PubMed ID: 17501993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helper virus-free herpes simplex virus-1 plasmid vectors for gene therapy of Parkinson's disease and other neurological disorders.
    Geller AI; Yu L; Wang Y; Fraefel C
    Exp Neurol; 1997 Mar; 144(1):98-102. PubMed ID: 9126158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.